These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2159251)

  • 21. Combination chemotherapy with S-1 and platinum in advanced hepatocellular carcinoma.
    Kim SJ; Han SW; Oh DY; Yi NJ; Kim YJ; Im SA; Yoon JH; Kang GH; Suh KS; Bang YJ; Jang JJ; Kim TY
    Anticancer Res; 2010 Dec; 30(12):5245-50. PubMed ID: 21187521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor necrosis factor induces hemorrhagic necrosis of a sarcoma.
    Robertson PA; Ross HJ; Figlin RA
    Ann Intern Med; 1989 Oct; 111(8):682-4. PubMed ID: 2802424
    [No Abstract]   [Full Text] [Related]  

  • 23. Magnetic polycarbonate microspheres for tumor-targeted delivery of tumor necrosis factor.
    Hu B; Du HJ; Yan GP; Zhuo RX; Wu Y; Fan CL
    Drug Deliv; 2014 May; 21(3):204-12. PubMed ID: 24117028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term use of indomethacin leads to poor prognoses through promoting the expression of PD-1 and PD-L2 via TRIF/NF-κB pathway and JAK/STAT3 pathway to inhibit TNF-α and IFN-γ in hepatocellular carcinoma.
    Xu P; Sun Z; Wang Y; Miao C
    Exp Cell Res; 2015 Sep; 337(1):53-60. PubMed ID: 26162855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Final and future frontiers.
    Friedman SL
    J Hepatol; 2014 Nov; 61(5):969-70. PubMed ID: 25149111
    [No Abstract]   [Full Text] [Related]  

  • 26. Angiogenesis blockade as therapy for hepatocellular carcinoma: progress and challenges.
    Hao CY
    J Gastroenterol Hepatol; 2011 Jan; 26(1):4-6. PubMed ID: 21175786
    [No Abstract]   [Full Text] [Related]  

  • 27. The GAPs between hepatocellular carcinoma and RAS.
    Guachalla LM; Rudolph KL
    J Hepatol; 2011 Feb; 54(2):191-2. PubMed ID: 21093951
    [No Abstract]   [Full Text] [Related]  

  • 28. Changes of AFPmRNA in blood after percutaneous ethanol injection treatment of hepatocellular carcinoma.
    Liu Y; Wu MC; Qian GX; Zhang BH
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):243-5. PubMed ID: 14612276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IFN-alpha-induced apoptosis in hepatocellular carcinoma involves promyelocytic leukemia protein and TRAIL independently of p53.
    Herzer K; Hofmann TG; Teufel A; Schimanski CC; Moehler M; Kanzler S; Schulze-Bergkamen H; Galle PR
    Cancer Res; 2009 Feb; 69(3):855-62. PubMed ID: 19141642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgen receptor and hepatocarcinogenesis: what do we learn from HCC mouse models?
    Zender L; Kubicka S
    Gastroenterology; 2008 Sep; 135(3):738-40. PubMed ID: 18692055
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment with inhibitors of angiogenesis in advanced hepatocellular carcinoma: a new tool in our hands or simply a hope?
    Cipriani G; Mazzanti R
    Dig Liver Dis; 2005 Apr; 37(4):230-1. PubMed ID: 15788205
    [No Abstract]   [Full Text] [Related]  

  • 32. Biochemical approaches to prediction of response in solid tumors.
    Wolberg WH
    Natl Cancer Inst Monogr; 1971 Dec; 34():189-95. PubMed ID: 4334726
    [No Abstract]   [Full Text] [Related]  

  • 33. Antitumor Efficacy of Huqizhengxiao (HQZX) Decoction Based on Inhibition of Telomerase Activity in Nude Mice of Hepatocarcinoma Xenograft.
    Yu X; Lin XJ; Wang S; Liu X; Li W; Kou BX; Chai M; Chen D; Liu X; Wang X
    Integr Cancer Ther; 2018 Dec; 17(4):1216-1224. PubMed ID: 29978739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyamine depletion of tumor tissue and subsequent elevation of spermidine in the sera of rats with 3924A hepatomas after 5-fluorouracil administration.
    Russell DH; Looney WB; Kovacs CJ; Hopkins HA; Marton LJ; LeGendre SM; Morris HP
    Cancer Res; 1974 Sep; 34(9):2382-5. PubMed ID: 4367291
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatomas: hormone receptors and therapy.
    Friedman MA; Demanes DJ; Hoffman PG
    Am J Med; 1982 Sep; 73(3):362-6. PubMed ID: 6289660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of two selenium sources on hepatocarcinogenesis and several angiogenic cytokines in diethylnitrosamine-induced hepatocarcinoma rats.
    Liu JG; Zhao HJ; Liu YJ; Liu YW; Wang XL
    J Trace Elem Med Biol; 2012 Oct; 26(4):255-61. PubMed ID: 22425635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model.
    Abdel-Hamid NI; El-Azab MF; Moustafa YM
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):379-395. PubMed ID: 28070612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ets-1 is increased in anticancer drug-containing media and hypoxic cultures, similar to TACE.
    Mamori S; Tajiri H
    Scand J Gastroenterol; 2009; 44(4):507-8. PubMed ID: 19107674
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatocellular carcinoma and the ubiquitin-proteasome system.
    Dawson SP
    Biochim Biophys Acta; 2008 Dec; 1782(12):775-84. PubMed ID: 18778769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A rare primary liver tumor that responded to sorafenib.
    Seino S; Tsuchiya A; Watanabe M
    Gastroenterology; 2014 Dec; 147(6):1226-7. PubMed ID: 25450081
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.